Myeloma Combination Cuts Line for FDA Approval After Strong ASH Results

(MedPage Today) — Under a program designed to accelerate the approval of products that could address key national priorities, the FDA awarded a national priority voucher to teclistamab (Tecvayli) in combination with daratumumab (Darzalex) for…